This Post Was Syndicated Under License Via QuoteMedia
WINNIPEG, Manitoba, Nov. 09, 2020 (GLOBE NEWSWIRE) — DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”), is pleased to announce that it has closed a transaction with Auxly Cannabis Group Inc. and Kolab Project Inc. (the “
”) to acquire all or substantially all of the Vendors’ assets relating to the operation of a retail cannabis store in Lloydminster, Saskatchewan (the “
”). The acquisition is anticipated to be completed through the Company’s wholly-owned subsidiary, Delta 9 Cannabis Store Inc., and pursuant to the previously announced purchase agreement among Delta 9 Cannabis Store Inc. and the Vendors dated August 31, 2020.
“We are pleased to have finalized our transaction with Auxly and Kolab to establish Delta 9’s first foothold in the Saskatchewan retail cannabis market,” said John Arbuthnot, CEO of Delta 9. “Delta 9’s strategy of vertical integration is further strengthened with the move into Saskatchewan, and unites Delta 9’s Western Canada retail strategy by joining its existing Manitoba and Alberta retail presence, and expands its base for future expansion opportunities.”
The purchase price paid by Delta 9 Cannabis Store Inc. relating to the Transaction was $875,000, subject to customary adjustments (the ”
“). $750,000 of the Purchase Price was satisfied through the issuance of 1,282,270 common shares in the capital stock of the Company (each a ”
“) at a deemed price of $0.5849 per Common Share, which is the 15-day volume weighted average price per Common Share on the Toronto Stock Exchange as at the closing date for the Transaction. The balance of the Purchase Price was paid in cash.
The final closing of the Transaction remains subject to the approval of the Toronto Stock Exchange.
For more information contact:
Investor & Media Contact:
Ian Chadsey VP Corporate Affairs
About Delta 9 Cannabis Inc.
Delta 9 Cannabis Inc. is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market. The company sells cannabis products through its wholesale and retail sales channels and sells its cannabis grow pods to other businesses. Delta 9’s wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. Delta 9’s shares trade on the Toronto Stock Exchange under the symbol “DN” and on the OTCQX under the symbol “VRNDF”. For more information, please visit www.delta9.ca.
Disclaimer for Forward-Looking
Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the
future business plans and other matters. Forward-looking statements consist of statements that are not purel
y historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Forward looking statements in this news release include statements relating t
potential expansion plans
and Toronto Stock Excha
nge approval for the Transaction being obtained
Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements,
as well as
all risk factors set forth in the annual information form of
March 19, 2020
which has been filed on SEDAR. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the
will obtain from them. Readers are urged to consid
er these factors carefully in evaluating the forward-looking statements contained in this news release and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. T
hese forward-looking statements are made as of the date hereof and the
disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as re
quired by applicable securities laws.